| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 05/12/2005 | US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate |
| 05/12/2005 | US20050101644 Benzylether amine compounds useful as CCR-5 antagonists |
| 05/12/2005 | US20050100787 High density; stability; n-heterocyclic polymer or oligomer |
| 05/12/2005 | CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 05/11/2005 | EP1529530A1 Compounds affecting glucokinase |
| 05/11/2005 | EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 05/11/2005 | EP1033362B1 Crystals of [s,s]-ethylenediamine-n,n'-disuccinic acid with high bulk density and method of obtaining the same |
| 05/06/2005 | WO2005040137A1 Aminoalkyl-pyrazinones and -pyridones as thrombin inhibitors |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050096337 for example (2-(3-methoxy-propyl)-4-{methyl-[2-methyl-6-(4-trifluoromethyl-phenyl)-pyridin-3-ylmethyl]-amino}-phenoxy)-acetic acid; Peroxisome Proliferator Activated Receptor (PPAR) activators; treating diabetes, dyslipidemia, cardiovascular disorders, polycystic ovary syndrome, proliferative disorders |
| 05/05/2005 | US20050096312 Antiserotonine agents; antidepressants; eating disorders; anxiolytic agents; sleep disorders; gastrointestinal disorders; cardiovascular disorders; muscular disorders; endocrine system diseases; muscular disorders; psychological disorders |
| 05/04/2005 | EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method |
| 05/04/2005 | CN1612763A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 05/03/2005 | US6887905 Treatment of depression or generalized anxiety disorder |
| 05/03/2005 | US6887875 2,5-diarypyrimidine compounds |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 05/03/2005 | CA2320388C Novel dihydroxyhexanoic acid derivatives |
| 04/28/2005 | WO2005037826A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | WO2005037809A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | WO2005037807A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 04/28/2005 | WO2005037803A1 Organic compounds |
| 04/28/2005 | WO2005037793A1 Cyclopentene compounds |
| 04/28/2005 | WO2005037786A1 Heterocyclyl compounds |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090630 Supported group 8-10 transition metal olefin polymerization catalysts |
| 04/28/2005 | US20050090559 Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| 04/28/2005 | US20050090503 5-HT receptor ligands and uses thereof |
| 04/28/2005 | CA2549733A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2541509A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | CA2540207A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | CA2539763A1 Phenylpiperazine cycloalkanol derivatives and methods of their use |
| 04/28/2005 | CA2539761A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 04/27/2005 | EP1526131A1 Aminoalkyl-pyrazinones and -pyridones as thrombin inhibitors |
| 04/27/2005 | EP1526127A2 Process for production of S,S-ethylenediamine-N,N'-disuccinic acid iron alkali salt |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1025097B1 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d 4? receptor subtype ligands |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy |
| 04/27/2005 | CN1610669A Heteroaryl-substituted aminocyclohexane derivatives |
| 04/27/2005 | CN1198839C Novel dipeptide amidines as thrombin inhibitors |
| 04/27/2005 | CN1198806C Oxodiethylenediamine derivative and light stabilized composition |
| 04/26/2005 | US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884477 Electroluminescence device using liquid crystal compound |
| 04/21/2005 | WO2005034857A2 Methods and compositions comprising diamines as new anti-tubercular therapeutics |
| 04/21/2005 | WO2004062601A3 Antibacterial agents |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085523 Imidazolyl and pyrazolyl ethyne compounds |
| 04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
| 04/21/2005 | US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 04/20/2005 | EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors |
| 04/20/2005 | CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties |
| 04/20/2005 | CN1608052A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 04/20/2005 | CN1197863C Novel octahydro-2H-pyridino-[1, 2-a] pyrazine compound, its prepn. process and medicinal compound contg. them |
| 04/20/2005 | CN1197856C Red fluorescence dyestuff and its synthesizing method and usage |
| 04/19/2005 | US6881727 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 04/14/2005 | WO2005033119A1 Supramolecular compounds and their use as antitumour and antiviral agents |
| 04/14/2005 | WO2005033105A2 Vanilloid receptor ligands and their use in treatments |
| 04/14/2005 | WO2005033088A1 Quinoxaline compounds |
| 04/14/2005 | WO2005016286A8 Pyrazine modulators of cannabinoid receptors |
| 04/14/2005 | US20050080267 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 04/14/2005 | US20050080263 Method for producing ss-heteroaryl-alpha-alanine compounds using 2-amino-2-(heteroarylmethyl) carboxylic acid compounds |
| 04/14/2005 | US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 04/14/2005 | US20050080092 Such as N-(6-aminohexyl)-N'-(3,5-diamino-6-chloropyrazine-2-carbonyl)guanidine Dihydrochloride; for hydration of mucosal surfaces, treating chronic bronchitis, cystic fibrosis, sinusitis, vaginal dryness, dry eye, esophogitis, emphysema, and pneumonia |
| 04/14/2005 | US20050080091 Capped pyrazinoylguanidine sodium channel blockers |
| 04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |
| 04/14/2005 | DE10343098A1 Tetrahydrochinoxaline und ihre Verwendung Tetrahydroquinoxalines and their use |
| 04/14/2005 | CA2540640A1 Vanilloid receptor ligands and their use in treatments |
| 04/14/2005 | CA2540638A1 Quinoxaline compounds |
| 04/13/2005 | EP1521748A1 Novel anthracene derivatives and the use thereof as a medicament |
| 04/13/2005 | CN1606548A Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives |
| 04/13/2005 | CN1606443A Substituted diketopiperazines as oxytocin antagonists |
| 04/13/2005 | CN1196681C (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers |
| 04/13/2005 | CN1196680C Modulators of dopamine neurotransmission |
| 04/12/2005 | US6878743 Controlling apoptosis; central nervous system disorders |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878712 E.g., (R)-((2S,5R)-2-methyl-5-methyl-4-(4-carboxyphenyl-sulphonyl)-1-(3,3,3 -trifluoro-2-hydroxy-2-methylpropionyl)-piperazine); antidiabetic agents |
| 04/12/2005 | US6878704 Heterocyclic mutilin esters and their use as antibacterials |
| 04/12/2005 | US6878700 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 04/12/2005 | CA2203936C Boronic ester and acid compounds, synthesis and uses |
| 04/12/2005 | CA2081836C Aromatic amidine derivatives and salts thereof |
| 04/07/2005 | WO2005030794A2 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | WO2004014871A8 Vanilloid receptor ligands and their use in treatments |
| 04/07/2005 | US20050075390 HIV protease inhibitors |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | CA2539823A1 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | CA2539444A1 Hexa- and octahydro-pyrido[1,2-a]pyrazine derivatives with nk1 antagonistic activity |
| 04/06/2005 | EP1520452A2 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/06/2005 | EP1520308A2 Polymeric charge transport compositions and electronic devices made with such compositions |
| 04/06/2005 | EP1520305A2 Charge transport compositions and electronic devices made with such compositions |
| 04/06/2005 | EP1519935A2 Charge transport compositions comprising fluorinated phenanthroline derivatives |